Correlation Between Cingulate Warrants and Skye Bioscience,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Skye Bioscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Skye Bioscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Skye Bioscience, Common, you can compare the effects of market volatilities on Cingulate Warrants and Skye Bioscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Skye Bioscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Skye Bioscience,.

Diversification Opportunities for Cingulate Warrants and Skye Bioscience,

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cingulate and Skye is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Skye Bioscience, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Skye Bioscience, Common and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Skye Bioscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Skye Bioscience, Common has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Skye Bioscience, go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Skye Bioscience,

Assuming the 90 days horizon Cingulate Warrants is expected to generate 2.05 times more return on investment than Skye Bioscience,. However, Cingulate Warrants is 2.05 times more volatile than Skye Bioscience, Common. It trades about 0.0 of its potential returns per unit of risk. Skye Bioscience, Common is currently generating about -0.06 per unit of risk. If you would invest  7.00  in Cingulate Warrants on September 13, 2024 and sell it today you would lose (3.63) from holding Cingulate Warrants or give up 51.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.41%
ValuesDaily Returns

Cingulate Warrants  vs.  Skye Bioscience, Common

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, Cingulate Warrants is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Skye Bioscience, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Skye Bioscience, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Cingulate Warrants and Skye Bioscience, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and Skye Bioscience,

The main advantage of trading using opposite Cingulate Warrants and Skye Bioscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Skye Bioscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Skye Bioscience, will offset losses from the drop in Skye Bioscience,'s long position.
The idea behind Cingulate Warrants and Skye Bioscience, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine